Newport News Speedway Track Preview
The Newport News Speedway is a track in development for rFactor. Under construction using 3D SimEd and Sandbox. Sorry about the commentary and rough driving. Track Length: 1/4 mile (300-foot straights, 360-foot corners) Track Width: 45 feet total (30-foot racing surface, 15-foot apron) Track Banking: 12 degrees corners, 6 degrees straights Pit Boxes: 30, pit limit 35.
View Count: 0 Date: June 23, 2011
-
Market Preview: Debt Ceiling, Geithner, Kodak
NEW YORK (TheStreet) -- Stocks roared back this week, but it still wasn't enough to put June in positive territory as the Dow Jones Industrial Average dipped 1.2%, losing ground for a second consecutive...
-
Market Preview: Jobless Claims, Kroger, Research In Motion
NEW YORK (TheStreet) -- Wall Street's confidence eroded post-haste on Wednesday as poor economic data again reared its head and Greece's not-so-sudden instability suddenly became problematic. The resulting...
-
Market Preview: Pandora's IPO, Finisar, CPI
NEW YORK (TheStreet) -- The market got a reprieve Monday from the rampant bearishness that's pervaded Wall Street for the past month as apparently salvation lies in still more shopping. The push vaulted...
-
Market Preview: Can Stocks Shake Weekly Losing Streak?
NEW YORK (TheStreet) -- Stocks finally found a reason to rally on Thursday, seizing on a jump in exports and a narrower than expected deficit to muster up the buying power to break a six-day losing...
-
Market Preview: ADP Report, Dollar General, Ford
NEW YORK (TheStreet) -- Even with Tuesday's smart gains, May was an ugly month for stocks. The Dow Jones Industrial Average finished down 241 points, or 1.9%, in May, its worst monthly performance on...
-
Finance and Administration meeting preview
By: BECKY HARRISÂ LOG CABIN STAFF WRITERÂ The Finance and Administration committee of the Faulkner County Quorum Court will meet at 5:30 p.m. Tuesday in the Courthouse Annex. read more
-
Earnings Preview: Merck to tout pipeline in report
Merck & Co., the world's second-biggest drugmaker by revenue, will focus on progress on its drug pipeline and cost cutting since its November 2009 acquisition of Schering-Plough Corp., when it reports...